Capricor Therapeutics
CAPR
#7632
Rank
โ‚ฌ0.43 B
Marketcap
7,49ย โ‚ฌ
Share price
0.93%
Change (1 day)
47.23%
Change (1 year)

Earnings for Capricor Therapeutics (CAPR)

Earnings in 2026 (TTM): -โ‚ฌ97.93 Million

According to Capricor Therapeutics 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -โ‚ฌ91.08 Million a decrease over its 2024 earnings that were of -โ‚ฌ35.09 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Capricor Therapeutics from 2001 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ97.93 Million7.53%
2025 -โ‚ฌ91.08 Million159.57%
2024 -โ‚ฌ35.09 Million81.57%
2023 -โ‚ฌ19.33 Million-23.2%
2022 -โ‚ฌ25.16 Million44.93%
2021 -โ‚ฌ17.36 Million46.61%
2020 -โ‚ฌ11.85 Million78.71%
2019 -โ‚ฌ6.63 Million-49.7%
2018 -โ‚ฌ13.18 Million-724.78%
2017 โ‚ฌ2.1 M-112.93%
2016 -โ‚ฌ16.31 Million46.27%
2015 -โ‚ฌ11.15 Million106.82%
2014 -โ‚ฌ5.39 Million-48.41%
2013 -โ‚ฌ10.45 Million977.23%
2012 -โ‚ฌ0.97 Million-77.11%
2011 -โ‚ฌ4.24 Million-22.35%
2010 -โ‚ฌ5.46 Million-20.17%
2009 -โ‚ฌ6.84 Million-41.17%
2008 -โ‚ฌ11.62 Million41.05%
2007 -โ‚ฌ8.24 Million1098.87%
2006 -โ‚ฌ0.69 Million4101.55%
2005 -โ‚ฌ0.02 Million-0.97%
2004 -โ‚ฌ0.02 Million17.87%
2003 -โ‚ฌ0.02 Million3.66%
2002 -โ‚ฌ0.02 Million-30.11%
2001 -โ‚ฌ0.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ22.52 B-22,770.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚ฌ0.69 B-797.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-โ‚ฌ0.72 Billion 623.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚ฌ0.27 Billion 169.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-โ‚ฌ5.42 Million-94.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-โ‚ฌ12.94 Million-86.98%๐Ÿ‡บ๐Ÿ‡ธ USA